Respiratory COPD Exacerbation vs Respiratory Notes
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
Respiratory COPD Exacerbation
Read full descriptionHide full description
"Respiratory COPD Exacerbation - BAP-65 and DECAF Score" is a mobile app designed to help with health practitioner in assessing the severity and predicting the outcome in acute exacerbation of chronic obstructive pulmonary disease (COPD) by using BAP-65 and DECAF Score. Chronic obstructive pulmonary disease (COPD) is defined as a common preventable and treatable disease, characterised by persistent airflow limitation that is usually progressive and associated with an enhanced chronic inflammatory response in the airways and the lung to noxious particles or gases. Exacerbations and comorbidities contribute to the overall severity in individual patients. There are several features of "Respiratory COPD Exacerbation - BAP-65 and DECAF Score", namely: - Simple and very easy to use COPD app. - Precise calculation and classification with BAP-65 score. - Easy calculation and interpretation of DECAF score. - Assess severity and predict outcome of acute COPD exacerbation. - It is totally free. Download now! Both BAP-65 and DECAF score in "Respiratory COPD Exacerbation - BAP-65 and DECAF Score" app correlates well with both in-hospital mortality and need for mechanical ventilation in patients with COPD. The BAP-65 system is a score composed of 4 variables. All of them are available upon presentation to the hospital. The B letter stands for Blood Urea Nitrogen (BUN) and it is positive if level is above 25 mg/dL. The A letter stands for Altered Mental Status and it is counted positive when the initial Glasgow Coma Scale (GCS) is 14 or less, or when the physician has designated that the patient was disoriented, stuporous or in coma. The P letter stands for Pulse and it is positive when the initial pulse is above 109 beats/min. Finally, an additional point will be added if the patient was above 65 years old. While DECAF score is a simple, reliable, accurate prediction tool could potentially improve patient care, by identifying patients suitable for hospital discharge or for more intensive therapy / monitoring. DECAF is simple to calculate and apply at the bedside. It requires an assessment of the patient’s usual level of breathlessness and function: the eMRCD score. Disclaimer: all calculations must be re-checked and should not be used alone to guide patient care, nor should they substitute for clinical judgment. Calculations in this "Respiratory COPD Exacerbation - BAP-65 and DECAF Score" app might be different with your local practice. Consult to expert doctor whenever necessary.
Respiratory Notes
This app provides a comprehensive, procedure-based reference for respiratory therapy information. It includes illustrations, forms, and algorithms to aid in study and practice, with content organized around protocols and new pulmonary disease tabs. An in-app purchase unlocks all content, and a subscription offers continuous updates.
- Procedure-based format
- Supporting illustrations and tables
- Fill-in-the-blank forms
- Algorithms based on AARC Guidelines
- SmartSearch technology
- Offline content access
Read full descriptionHide full description
"Try before you buy"" - Download the FREE App, which includes sample content. An in-App purchase is required to unlock all content. Procedure-based format, all the respiratory therapy information you need at your fingertips. Respiratory Notes: Respiratory Therapist's Pocket Guide a quick-reference tool that put all the respiratory therapy information you need at your fingertips. The procedure-based format includes supporting illustrations, fill-in-the-blank forms, and algorithms to help you study and guide you in practice. Key Features * Bullet-point reviews guide you through procedures. * Quick-scan illustrations and tables summarize data. * Algorithms are based on AARC Clinical Practice Guidelines. * Key forms allow you to gather data at the bedside, and then transcribe to conventional charts New to this Edition * NEW! Pulmonary Disease and Airway/Ventilation Tabs * NEW! Comprehensive index * UPDATED! Procedures now organized around protocols No internet connection is required to access the content after the initial download. Find information quickly using powerful SmartSearch technology. Search part of term for those hard to spell medical terms. Content licensed from printed ISBN 10: 0803629222 Content licensed from printed ISBN 13: 9780803629226 SUBSCRIPTION : Please choose an auto renewable subscription plan to receive content access & continuous updates. Your subscription automatically renews as per your plan, so you always have the latest content. Yearly auto-renewing payments - $29.99 Payment will be charged to your iTunes Account at confirmation of purchase. Subscription automatically renews unless auto-renew is turned off at least 24-hours before the end of the current period. Subscription may be managed by the user & auto-renewal can be disabled at any time by going to your device “Settings” and tapping “iTunes & App Store”. Any unused portion of a free trial period will be forfeited when you purchase a subscription, where applicable. If you have any questions or comments, email us any time: customersupport@skyscape.com or call 508-299-30000 Privacy Policy-https://www.skyscape.com/terms-of-service/privacypolicy.aspx Terms and Conditions-https://www.skyscape.com/terms-of-service/licenseagreement.aspx Editor(s): Gary C. White MEd RRT RPFT Publisher: F. A. Davis Company
Screenshots
Verdict
The clearest difference is in-app purchases: Respiratory COPD Exacerbation at none against Respiratory Notes's 1. Respiratory COPD Exacerbation also leads on ads (none vs shown) and update cadence (every 2 months vs every 6 months). On price and device support there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Respiratory Notes sells 1 in-app purchase, starting at $39.99 per year. Respiratory COPD Exacerbation asks for nothing beyond the download.
Respiratory COPD Exacerbation ships an update every 2 months, Respiratory Notes every 6 months. The most recent releases landed on October 2, 2026 and September 30, 2026 respectively.
| Parameter | Respiratory COPD Exacerbation | Respiratory Notes |
|---|---|---|
| Price | Free | Free |
| Rating | — | 4.0 (4 ratings) — better |
| Number of ratings | — | 4 — better |
| Update frequency | Every 2 months — better | Every 6 months |
| Ads | No — better | Yes |
| In-app purchases | No — better | Yes |
| Monetization | — | Free with in-app purchases |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 11.0 — better | 13.0 |
| Further details — not scored | ||
| Size | 37 MB | 47 MB |
| Age rating | 12+ | 17+ |
| Developer | Putu Angga Risky Raharja | Skyscape Medpresso Inc |
In-app purchases
Respiratory COPD Exacerbation
No in-app purchases
Respiratory Notes
- Respiratory Notes$39.991 Year
Questions
Is Respiratory COPD Exacerbation free?
Is Respiratory Notes free?
Do Respiratory COPD Exacerbation or Respiratory Notes have ads?
Which is updated more often, Respiratory COPD Exacerbation or Respiratory Notes?
Other comparisons















